"We Envision Growth Strategies Most Suited
to Your Business"
The global Non Invasive prenatal testing (NIPT) market size is expected to gain momentum by reaching USD 13.16 billion by 2028 from USD 4.11 billion in 2021. This information is published by Fortune Business Insights in its report, titled “Non Invasive Prenatal Testing (NIPT) Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments, and Consumables & Reagents), Technology (Next Generation Sequencing, Microarray, PCR, and Rolling Circular Amplification), End-User (Hospitals, and Clinical Laboratories) and Regional Forecast, 2021-2028.” The report further observes that the market stood at USD 3.48 billion in 2020 and is projected to exhibit a CAGR of 18.1% between 2021 and 2028.
Illumina Partners Next Generation Genome to Introduce VeriSeq NIPT Solution across Thailand
In May 2021, Illumina, Inc., a leading player in the development of DNA sequencing technologies, announced its partnership with Thailand-based Next Generation Genome Co., Ltd. (NGG) The partnership is aimed at the development and launch of VeriSeq Non Invasive Prenatal Testing Solution v2 in Thailand. According to the companies, the automated in-lab solution NGG to introduce the Qualifi Prenatal Test and be the first-ever laboratory to ensure accurate detection of anomalies that targets assays miss while delivering detailed insights on the health of a pregnant woman. Such initiatives are expected to provide the patients with personalized and timely pregnancy management options that will help to empower their journey through pregnancy.
To get a detailed report summary and research scope of this market, click here:
https://www.fortunebusinessinsights.com/industry-reports/non-invasive-prenatal-testing-market-100998
Continual Product Innovations to Surge Product Demand
In 2019, Progenity, Inc., a leading biotechnology company, introduced Resura Prenatal Test for Monogenic Disease, a customizable NIPT for single-gene disorders. Several companies like Progenity, Inc. focus on the development of advanced screening technologies that are accurate in early detection of genetic disorders in babies. In addition, screening policies adopted by several governments worldwide is expected to bode well for the global Non Invasive prenatal testing market growth during the forecast period. For instance, in 2018, the National Health Service (NHS) announced the implementation of initiatives involving promotions of NIPT solutions in their public health policies.
Contract Signing by Prominent Companies to Propel Market Growth
The global market is experiencing high competition from the players present in it that are focusing on signing lucrative contracts to expand their product portfolio. Moreover, other key players are striving to maintain their presence by focusing on leveraging the market opportunities by following organic and inorganic strategies in the forthcoming years.
Industry Development:
List of the Companies Profiled in the Market
Further Report Findings:
Table of Segmentation:
ATTRIBUTE | DETAILS |
Study Period | 2017-2028 |
Base Year | 2020 |
Forecast Period | 2021-2028 |
Historical Period | 2017-2019 |
Unit | Value (USD Billion) |
Segmentation | Product; Technology; End User and Geography |
By Product |
|
By Technology
|
|
By End User |
|
By Region |
|